Investor Presentaiton

Focus Areas of Today's Discussion on RMS Segment Charles River Laboratories (CRL) Accelerated growth • Sustained long-term RMS growth potential through leading position, global scale, and focus on emerging areas of growth • China and CRADL™M China and CRADL™ remain two of the most meaningful growth drivers, as well as opportunities across our broader service offering and in key biohubs Digitally enabled Inventory optimization and e-commerce initiatives are transforming the speed and efficiency of this 75-year-old business 2

View entire presentation